Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

California · 2025–26 Regular Session · Assembly Bill

AB 242: Genetic disease screening.

Did not advance Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted
  6. Did not advance

Last official action: ·Record last updated:

Plain-language summary

AB 242 is a assembly bill introduced in the California Assembly on January 14, 2025. According to its official title, it concerns: Genetic disease screening. Primary sponsor: Tasha Boerner (D). Most recent recorded action (February 2, 2026): From committee: Filed with the Chief Clerk pursuant to Joint Rule 56.

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Official summary

Legislative Counsel’s Digest (official, as of the latest version). Written by nonpartisan legislative staff; reproduced verbatim.

Existing law requires the State Department of Public Health to establish a program for the development, provision, and evaluation of genetic disease testing.

Existing law establishes the continuously appropriated Genetic Disease Testing Fund (GDTF), consisting of fees paid for newborn screening tests, and states the intent of the Legislature that all costs of the genetic disease testing program be fully supported by fees paid for newborn screening tests, which are deposited in the GDTF. Existing law also authorizes moneys in the GDTF to be used for the expansion of the Genetic Disease Branch Screening Information System to include cystic fibrosis, biotinidase, severe combined immunodeficiency (SCID), adrenoleukodystrophy (ALD), and any other disease that is detectable in blood samples, as specified, and exempts the expansion of contracts for this purpose from certain provisions of the Public Contract Code, the Government Code, and the State Administrative Manual, as specified.

This bill would require the department to expand statewide screening of newborns to include screening for Duchenne muscular dystrophy as soon as possible, but no later than January 1, 2027. By expanding the purposes for which moneys from the GDTF may be expended, this bill would make an appropriation.

Sponsors

Sponsors by party (alphabetical): Democratic 1

NameRolePartyChamberDistrict
Tasha BoernerPrimary sponsorDemocraticAssembly77

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. From committee: Filed with the Chief Clerk pursuant to Joint Rule 56.
  2. Died pursuant to Art. IV, Sec. 10(c) of the Constitution.
  3. In committee: Held under submission.
  4. In committee: Set, first hearing. Referred to suspense file.
  5. From committee: Do pass and re-refer to Com. on APPR. with recommendation: To Consent Calendar. (Ayes 15. Noes 0.) (April 1). Re-referred to Com. on APPR.
  6. In committee: Hearing postponed by committee.
  7. Referred to Com. on HEALTH.
  8. From printer. May be heard in committee February 14.
  9. Read first time. To print.

Sources

  1. California Legislative Information — pubinfo database export
  2. Official bill page